David D Muth - Net Worth and Insider Trading
David D Muth Net Worth
The estimated net worth of David D Muth is at least $675,864 dollars as of 2024-04-25. David D Muth is the EVP, Chief Commercial Officer of Catalyst Pharmaceuticals Inc and owns about 44,700 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $675,864. Details can be seen in David D Muth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David D Muth has not made any transactions after 2015-05-01 and currently still holds the listed stock(s).
Transaction Summary of David D Muth
David D Muth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David D Muth owns 1 companies in total, including Catalyst Pharmaceuticals Inc () .
Click here to see the complete history of David D Muth’s form 4 insider trades.
Insider Ownership Summary of David D Muth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | 2015-05-01 | Exec. V.P. & Corp. Development |
David D Muth Latest Holdings Summary
David D Muth currently owns a total of 1 stock. David D Muth owns 44,700 shares of Catalyst Pharmaceuticals Inc (CPRX) as of May 1, 2015, with a value of $675,864.
Latest Holdings of David D Muth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2015-05-01 | 44,700 | 15.12 | 675,864 |
Holding Weightings of David D Muth
David D Muth Form 4 Trading Tracker
According to the SEC Form 4 filings, David D Muth has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the acquisition of 1,700 shares on May 1, 2015, which cost David D Muth around $5,440.
Insider Trading History of David D Muth
- 1
David D Muth Trading Performance
GuruFocus tracks the stock performance after each of David D Muth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David D Muth is 47.84%. GuruFocus also compares David D Muth's trading performance to market benchmark return within the same time period. The performance of stocks bought by David D Muth within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David D Muth's insider trading performs compared to the benchmark.
Performance of David D Muth
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.03 | 47.84 | -3.26 | -80.88 | -27.21 | -5.84 |
| Relative Return to S&P 500(%) | 16.8 | 48.45 | -2 | -78.94 | -33.51 | -13.87 |
David D Muth Ownership Network
Ownership Network List of David D Muth
Ownership Network Relation of David D Muth
David D Muth Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
David D Muth is the Exec. V.P. & Corp. Development of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Compliance/Legal Officer Brian Elsbernd , Chief Accounting Officer Alicia Grande , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, David D Muth made no insider transaction in Catalyst Pharmaceuticals Inc (). Other recent insider transactions involving Catalyst Pharmaceuticals Inc () include a net sale of 430,000 shares made by Alicia Grande , a net sale of 105,000 shares made by David S Tierney , and a net sale of 89,666 shares made by Brian Elsbernd .
In summary, during the past 3 months, insiders sold 50,000 shares of Catalyst Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 1,804,523 shares of Catalyst Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,523 shares.
Catalyst Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
David D Muth Mailing Address
Above is the net worth, insider trading, and ownership report for David D Muth. You might contact David D Muth via mailing address: Catalyst Pharmaceutical Partners, Inc., 355 Alhambra Circle, Suite 1500, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
